Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Lisa M. Lowenstein Image

      Lisa M. Lowenstein, PhD, MPH, RD

      Department of Health Services Research, Division of Cancer Prevention and Population Sciences

      Present Title & Affiliation

      Primary Appointment

      Associate Professor (Term Tenure Track), Health Services Research, Division of OVP, Cancer Prevention and Population Science, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Education & Training

      Degree-Granting Education

      2011University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, US, Ph.D. in Nutrition
      2006University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, US, MPH in Nutrition
      2003University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, US, BS in Biology, Psychology

      Postgraduate Training

      2011-2013Postdoctoral Fellowship, Preventive Cardiology, University of Rochester, Rochester, New York
      2008-2011Leadership Education in Adolescent Health (LEAH) Fellow, The University of Rochester, Rochester, New York

      Licenses & Certifications

      2006Commission on Dietetic Registration

      Experience & Service

      Faculty Academic Appointments

      Assistant Professor, Health Services Research, Division of OVP, Cancer Prevention and Population Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2022 - 2024

      Assistant Professor, Health Services Research, Division of OVP, Cancer Prevention and Population Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2016 - 2022

      Instructor, Health Services Research, Division of OVP, Cancer Prevention and Population Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2015 - 2016

      Research Assistant Professor, Department of Medicine, Hematology/Oncology, The University of Rochester, Rochester, New York, 2014 - 2015

      Administrative Appointments/Responsibilities

      Co-Director, Education Programs, Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2025 - Present

      Co-Director, Texas Decision Science Core: A CPRIT Population Science Core, Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present

      Co-Director Decision Science Core Resource, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - 2026

      Director of Implementation Science, Decision Science Core Resource, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2021 - 2023

      Founder and Lead, MD Anderson Dissemination and Implementation Working Group, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2020 - Present

      Director of Implementation Science for the Decision Support Lab, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2019 - Present

      Decision Science Implementation Lead, Shared Decision-Making Collaborative, Duncan Family Institute for Cancer Prevention and Risk Assessment, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2016 - 2020

      Intramural Institutional Committee Activities

      Member, Health Services Research Faculty Search Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present

      Judge, Quality Improvement, MD Anderson Trainee Research Day - Oral Competition, The University of Texas MD Anderson Cancer Center, 2021

      Member, Population Health Evaluation Core at MD Anderson Working Group, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Member, MD Anderson Cancer Center Support Grant (CCSG) - Cancer Prevention Program, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Member, UTH-MDA Population Health Initiative Research Workgroup, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Member, MD Anderson Cancer Center Support Grant (CCSG) – Risk Detection and Outcome Program, The University of Texas MD Anderson Cancer Center, 2020 - 2023

      Member, Review Committee for NCI R25E Summer Program Applications - Cancer Prevention Research Training Program (CPRTP), The University of Texas MD Anderson Cancer Center, Houston, TX, The University of Texas MD Anderson Cancer Center, 2016 - Present

      Extramural Institutional Committee Activities

      Expert Panel Member, Technical Panel, Geriatric Evaluation Measure Technical Expert Panel, American Society of Clinical Oncology (ASCO), 2025 - Present

      Member, Symptom and Quality of Life Steering Committee, Symptom Management and Health Related Quality of Life Steering Committee National Cancer Institute (NCI), 2022 - Present

      Expert Panel Member, Guideline for the Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy, American Society of Clinical Oncology (ASCO), 2022 - 2023

      Member, Health Services Core, Cancer and Aging Research Group, 2019 - Present

      Editorial Activities

      Member of Editorial Review Board, Journal of Geriatric Oncology, 2018 - Present

      Professional Memberships

      International Society of Shared Decision Making

      2026 - Present

      American Society of Clinical Oncology

      2025 - Present

      International Society of Geriatric Oncology

      2019 - Present

      Dissemination and Implementation Committee, Alliance for Clinical Trials in Oncology

      2017 - 2022

      Cancer Care Delivery Research Committee; Alliance for Clinical Trials in Oncology

      2016 - Present

      Society of Medical Decision Making

      2016 - Present

      Academy Health

      2015 - Present

      Cancer and Aging Research Group

      2015 - Present

      Society of Behavioral Medicine

      2010 - 2018

      American Public Health Association

      2007

      Selected Presentations & Talks

      Formal Peers

      1. 2023. Invited Senior Faculty Mentor, Cancer, and Aging Research Group (CARG) Career Development Workshop. City of Hope, CA, US.
      2. 2023. Invited Senior Faculty Mentor, Specific Aims Cancer and Aging Research Group (CARG) Career Development Workshop. City of Hope, CA, US.
      3. 2021. Overview of Dissemination and Implementation Science. Invited. City of Hope, CA, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2026 - 2031
      Title:Leveraging tobacco quitlines to disseminate lung cancer screening educational materials for persons who smoke
      Funding Source:NIH
      Role:Principal Investigator
      ID:CA315499
      Date: 2026 - 2028
      Title:Leveraging Health Systems to Increase Implementation of Evidence-Based Surgical Cancer Care
      Funding Source:NIH/NCI
      Role:Mentor
      ID:CA283001
      Date: 2025 - 2030
      Title:Increasing Uptake of Germline Genetic Testing among Prostate Cancer Patients in a Diverse Safety Net Hospital
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Advisor
      ID:RP250475
      Date: 2025 - 2031
      Title:Practical Delivery of Geriatric Assessment in Community Oncology Settings
      Funding Source:NIH/NCI
      Role:Co-I
      ID:UG3CA293878
      Date: 2025 - 2029
      Title:Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel Intrauterine Device for Primary Prevention of Endometrial Cancer
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Collaborator
      ID:RP250293
      Date: 2025 - 2025
      Title:Financial Burden in Chronic Cancer Survivors
      Funding Source:HCSC Blue Cross Blue Shield
      Role:Site Principal Investigator
      ID:ZY26562
      Date: 2025 - 2025
      Title:Facilitators and Barriers to Cancer Treatment Among Texas Medicare Beneficiaries
      Funding Source:Institutional Research Grant (IRG)
      Role:Co-I
      Date: 2024 - 2027
      Title:A Virtual, Centralized Lung Cancer Screening Program for Northeast Texas
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Co-PD
      ID:PP250004
      Date: 2024 - 2029
      Title:The Texas Decision Science Core Facility: A CPRIT Population Science Core
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Co-I
      ID:RP240508
      Date: 2024 - 2028
      Title:Center for Transformative Community-Driven Research to Prevent Obesity-related Cancer
      Funding Source:National Institutes of Health
      Role:Co-I
      ID:1U54CA280804-01
      Date: 2023 - 2028
      Title:Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery
      Funding Source:Rising Tide Foundation
      Role:Co-I
      ID:CCR-23-500
      Date: 2023 - 2030
      Title:Engaging Patients in Decision-Making: The Development and Pilot Testing of a Low Literacy Spanish Language Shared Medical Decision Tool for Ovarian Cancer Maintenance Therapy
      Funding Source:Merck
      Role:Co-I
      ID:2022-0539
      Date: 2023 - 2028
      Title:Multicomponent Interventions to Improve Uptake and Adherence to Lung Cancer Screening
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Co-I
      ID:RP230213
      Date: 2023 - 2026
      Title:Taking Texas Tobacco Free: Dissemination to and Implementation within Lung Cancer Screening Programs
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Co-I
      ID:PP230002
      Date: 2023 - 2025
      Title:Proteus Consortium and Pfizer Global Medical Grant for Applying Patient-Reported Outcomes in Oncology
      Funding Source:Pfizer
      Role:Co-I
      ID:73555661
      Date: 2022 - 2027
      Title:TELEhealth Shared Decision-Making Coaching for Lung Cancer Screening in Primary Care (TELESCOPE)
      Funding Source:NIH/NHLBI
      Role:Co-I
      ID:R01 HL158850-01A1
      Date: 2022 - 2025
      Title:Adaptation and Pilot Testing of a Lung Cancer Screening Decision Aid for Patients from a Safety-Net Healthcare System
      Funding Source:Quasi Endowment (QE) Community Outreach
      Role:Co-I
      Date: 2022 - 2025
      Title:Implementing an Intervention to Address Concerns of Older Patients with Cancer Receiving Chemotherapy and Their Caregivers
      Funding Source:Patient-Centered Outcomes Research Institute (PCORI)
      Role:Principal Investigator
      ID:DI-2020C3_21003
      Date: 2021 - 2023
      Title:Design and Launch of a Dissemination and Implementation Graduate Certificate Program
      Funding Source:UTH-MDA Population Health Initiative Collaborative Projects Fund
      Role:Principal Investigator-MDACC
      Date: 2019 - 2022
      Title:Implementing Patient Decision Support for Lung Cancer Screening through Tobacco Quitlines
      Funding Source:Patient-Centered Outcomes Research Institute (PCORI)
      Role:Co-PI
      ID:FP00007237
      Date: 2019 - 2023
      Title:Financial Burden in Chronic Cancer Survivors
      Funding Source:BCBS
      Role:Co-I
      Date: 2019 - 2025
      Title:Alliance NCORP Research Base
      Funding Source:NIH/NCI
      Role:Co-I
      ID:5 UG1 CA 189823-05
      Date: 2019 - 2026
      Title:Cancer Center Support (CORE) Grant
      Funding Source:NIH/NCI
      Role:Co-I
      ID:P30CA016672 - 47
      Date: 2019 - 2024
      Title:Improving the Quality of Smoking Cessation and Shared Decision-Making for Lung Cancer Screening: A Cluster Randomized Trial
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Co-I
      ID:RP190210
      Date: 2019 - 2024
      Title:Older Men's Decision Making about Active Surveillance for Prostate Cancer
      Funding Source:American Cancer Society (ACS)
      Role:PI
      ID:MRSG-18-225-01-CPPB
      Date: 2017 - 2018
      Title:Tumor Board Project
      Funding Source:American College of Surgeons
      Role:Co-PI
      Date: 2017 - 2020
      Title:Development of a Shared Medical Decision-Making Tool for Maintenance Therapy in Ovarian Cancer
      Funding Source:AstraZeneca (AZ) Alliance
      Role:Collaborator
      ID:2017-0062
      Date: 2017 - 2018
      Title:Capacity Constraints for Lung Cancer Screening Facilities in Providing Smoking Cessation
      Funding Source:CCSG Prevention and Population Science Research Programs Seed Funding Initiative
      Role:Co-PI
      Date: 2016 - 2017
      Title:Promoting Informed Decisions about Lung Cancer Screening
      Funding Source:Patient-Centered Outcomes Research Institute (PCORI)
      Role:Co-I
      ID:CER-1306-03385
      Date: 2016 - 2017
      Title:Research and Development of IDM/SDM tools for the American Cancer Society: A Proposal from The University of Texas MD Anderson Cancer Center
      Funding Source:American Cancer Society (ACS)
      Role:Co-I
      ID:41222
      Date: 2016 - 2021
      Title:Economic Strain and Resilience in Cancer Patients: Assessing Patient-Reported Measures of the Burdens of Treatment
      Funding Source:NIH/NCI
      Role:Collaborator
      ID:K07CA211804-01
      Date: 2016 - 2022
      Title:Comparative Effectiveness Research on Cancer in Texas (CERCIT) 2.0: Survey Core
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Co-I
      ID:RP160674
      Date: 2016 - 2018
      Title:Economic Strain and Resilience in Cancer Patients: Incorporating and Measuring Patient Perspectives on the Hidden Burdens of Treatment
      Funding Source:The University of Texas MD Anderson Cancer Center
      Role:Collaborator
      ID:RCTS 2016-52176-Y1
      Date: 2015 - 2019
      Title:Shared Decision-Making Collaborative
      Funding Source:Duncan Family Institute (DFI)
      Role:Collaborator
      ID:115296
      Date: 2014 - 2017
      Title:The John M. Eisenberg Center for Clinical Decisions and Communications Science
      Funding Source:Agency for Healthcare Research and Quality (AHRQ)
      Role:Co-I
      ID:HHSA-290201500002C
      Date: 2014 - 2019
      Title:Methods Training in Patient-Centered Cancer Outcomes Research
      Funding Source:Agency for Healthcare Research and Quality (AHRQ)
      Role:Collaborator
      ID:1R25HS023214
      Date: 2014 - 2017
      Title:Patient-Centered Risk Adjusted Surveillance After Curative Resection of Colorectal Cancer
      Funding Source:Patient-Centered Outcomes Research Institute (PCORI) (contract with the Alliance for Clinical Trials in Oncology)
      Role:Co-I
      ID:CE-1304-6855
      Date: 2013 - 2018
      Title:Reducing Chemotherapy Toxicity in Older Patients
      Funding Source:NIH/NCI
      Role:Program Manager
      ID:1R01-CA177592-01
      Date: 2011 - 2013
      Title:Research Training in Preventive Cardiology
      Funding Source:NHLBI
      Role:Trainee
      ID:5-T32-HL-7937-12
      Date: 2008 - 2010
      Title:Leadership Education in Adolescent Health (LEAH) Fellowship
      Funding Source:MCH
      Role:Trainee
      Date: 2005 - 2011
      Title:Primary Care And Communities Tackling Obesity In Kids
      Funding Source:NICHD
      Role:Graduate Research Assistant
      ID:1R01-HD50981-01

      Selected Publications

      Peer-Reviewed Articles

      1. Rogova, A, Reitzel, LR, Lowenstein, LM, Cinciripini, PM, Britton, MK, Volk, R, Fox, JG, Chen, TA, Minnix, JA. Implementation of a hybrid lung health program for Northeast Texas. Implementation Science Communications 7(1), 2026. e-Pub 2026. PMID: 41709306.
      2. Tan, NQ, Lopez-Olivo, MA, Mendoza, TR, Crocker, LC, Sepucha, KR, Nishi, S, Volk, R, Lowenstein, LM. Development and psychometric evaluation of a decision quality instrument for lung cancer screening decisions (DQI-LCS). BMC Medical Informatics and Decision Making 26(1), 2026. e-Pub 2026. PMID: 41723422.
      3. Jackson I, Lowenstein LM, Brewster AM. A pilot study of a behavior-change intervention for preventive therapy among women at high risk for invasive breast cancer. BMC Medical Informatics and Decision Making 26(1), 2026. e-Pub 2026. PMID: 42001127.
      4. Lee HJ, DeBoer RJ, Suchman L, Lowenstein LM, Boscardin WJ, Nicosia FM, Litt HK, Walter LC, Smith AK, Loh KP, Huang L, Morales D, Mohile SG, Volk RJ, Mercurio AM, Sedrak MS, Nipp R, Arora SP, Carter-Bawa L, Schwarze ML, Wong ML. “The tool helped me feel more confident in that decision”: Cluster randomized pilot of Best Case/Worst Case-Geriatric Oncology for older adults with cancer. J Natl Compr Canc Netw. e-Pub 2026.
      5. Eversole, EA, Cha, E, Al-Sharfeen, A, Chen, A, Marquez, C, Peek, A, Peterson, SK, Lowenstein, LM, Swanson, DM, Klopp, AH, Lin, LL. Patient-reported outcomes as a tool for enhanced symptom management in gynecologic radiation oncology. JCO Oncology Practice 21:388, 2025. e-Pub 2025.
      6. Eversole, EA, Cha, E, Alatrach, M, Marquez, C, Peek, A, Lin, LL, Lowenstein, LM, Peterson, SK, Swanson, DM, Liao, Z, Chen, A. Leveraging patient-reported outcomes for enhanced symptom management among thoracic radiation patients. JCO Oncology Practice 21:381, 2025. e-Pub 2025.
      7. Mejia MC, Ma YH, Lowenstein LM, Spooner KK, Duhon G, Douglas EE, Leal V, Volk RJ. Provider readiness and implementation barriers for lung cancer screening in a safety-net system. Prev Med Rep 56:103164, 2025. e-Pub 2025. PMID: 40687059.
      8. Siddiqi AD, Britton M, Martinez Leal I, Taing M, Chen TA, Lowenstein LM, Minnix JA, Reitzel LR. Project SWITCH Study Protocol: A Tobacco-Free Workplace Program for Dissemination and Implementation in Lung Cancer Screening Centers. Methods Protoc 8(4), 2025. e-Pub 2025. PMID: 40700308.
      9. Hernandez M, Rogova A, Reitzel LR, Lowenstein LM, Volk RJ. Cigarette use, lung cancer screening eligibility and completion among persons with poor mental health. Cancer Med 14(11):e70983, 2025. e-Pub 2025. PMID: 40444443.
      10. Rogova, A, Martinez Leal, I, Britton, MK, Chen, TA, Lowenstein, LM, Kyburz, B, Casey, K, Skeene, K, Williams, T, Reitzel, LR. Implementing a tobacco-free workplace program at a substance use treatment center. BMC Health Services Research 24(1), 2024. e-Pub 2024. PMID: 38355470.
      11. Tan NQP, Lowenstein LM, Douglas EE, Silva J, Bershad JM, An J, Shete SS, Steinberg MB, Ferrante JM, Clark EC, Natale-Pereira A, Sahu NN, Hastings SE, Hoffman RM, Volk RJ, Kinney AY. The TELEhealth Shared decision-making COaching and navigation in Primary carE (TELESCOPE) intervention: a study protocol for delivering shared decision-making for lung cancer screening by patient navigators. BMC Prim Care 25(1):373, 2024. e-Pub 2024. PMID: 39425032.
      12. Chang GJ, Gunn HJ, Barber AK, Lowenstein LM, Dohan D, Broering J, Dockter T, Tan AD, Dueck A, Chow S, Neuman H, Finlayson E. Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of a Presurgical Toolkit (OPTI-Surg)-Final Results of a Phase III Cluster Randomized Trial (Alliance A231601CD). Ann Surg 280(4):623-632, 2024. e-Pub 2024. PMID: 39069901.
      13. Tan NQP, Volk RJ, Leal VB, Lettieri JS, Bailey LA, Ylioja T, Celestino P, Lowenstein LM. Tobacco quitline staffs' knowledge and attitudes about connecting quitline callers to lung cancer screening educational materials. Cancer Med 13(13):e7443, 2024. e-Pub 2024. PMID: 38940442.
      14. Dale W, Klepin HD, Williams GR, Alibhai SMH, Bergerot C, Brintzenhofeszoc K, Hopkins JO, Jhawer MP, Katheria V, Loh KP, Lowenstein LM, McKoy JM, Noronha V, Phillips T, Rosko AE, Ruegg T, Schiaffino MK, Simmons JF Jr, Subbiah I, Tew WP, Webb TL, Whitehead M, Somerfield MR, Mohile SG. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update. J Clin Oncol 41(26):4293-4312, 2023. e-Pub 2023. PMID: 37459573.
      15. Williams GR, Hopkins JO, Klepin HD, Lowenstein LM, Mackenzie A, Mohile SG, Somerfield MR, Dale W. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Questions and Answers. JCO Oncol Pract 19(9):718-723, 2023. e-Pub 2023. PMID: 37459585.
      16. Hoffman RM, Lang JA, Bailey GJ, Merchant JA, Seaman AS, Newbury EA, Sanchez R, Volk RJ, Lowenstein LM, Averill SL. Implementing a Telehealth Shared Counseling and Decision-Making Visit for Lung Cancer Screening in a Veterans Affairs Medical Center. Fed Pract 40(Suppl 3):S83-S90, 2023. e-Pub 2023. PMID: 38021099.
      17. Lowenstein LM, Shih YT, Minnix J, Lopez-Olivo MA, Maki KG, Kypriotakis G, Leal VB, Shete SS, Fox J, Nishi SP, Cinciripini PM, Volk RJ. A protocol for a cluster randomized trial of care delivery models to improve the quality of smoking cessation and shared decision making for lung cancer screening. Contemp Clin Trials 128:107141, 2023. e-Pub 2023. PMID: 36878389.
      18. Britton M, Chen TA, Martinez Leal I, Rogova A, Kyburz B, Williams T, Patel M, El-Zein R, Bernicker EH, Lowenstein LM, Reitzel LR. Lung Cancer Screening Eligibility and Referral Practices in Texas Organizations Serving People with Substance Use Disorders. Cancers (Basel) 15(7), 2023. e-Pub 2023. PMID: 37046736.
      19. Barnett S, Matthews K, DeWindt L, Sutter E, Samuel-Hodge C, Yang H, Pearson TA, study group) DWWSG(APOT. Deaf Weight Wise: A Novel Randomized Clinical Trial with Deaf Sign Language Users. Obesity (Silver Spring), 2023. e-Pub 2023. PMID: 36890106.
      20. Mehta SN, Shenvi EC, Blair SL, Caudle A, Lowenstein LM, Kelly KJ. Leveraging the Multidisciplinary Tumor Board for Dissemination of Evidence-Based Recommendations on the Staging and Treatment of Gastric Cancer: A Pilot Study. Ann Surg Oncol 30(2):1120-1129, 2023. e-Pub 2023. PMID: 36222932.
      21. De B, Lowenstein LM, Corrigan KL, Andring LM, Kuban DA, Cantor SB, Volk RJ, Hoffman KE. Patients' Preferences for Androgen Deprivation Therapy in the Treatment of Intermediate-Risk Prostate Cancer. MDM Policy Pract 7(2):23814683221137752, 2022. e-Pub 2022. PMID: 36405544.
      22. Lowenstein LM, Nishi SPE, Lopez-Olivo MA, Crocker LC, Choi N, Kim B, Shih YT, Volk RJ. Smoking cessation services and shared decision-making practices among lung cancer screening facilities: A cross-sectional study. Cancer 128(10):1967-1975, 2022. e-Pub 2022. PMID: 35157302.
      23. Tan NQP, Nishi SPE, Lowenstein LM, Mendoza TR, Lopez-Olivo MA, Crocker LC, Sepucha KR, Volk RJ. Impact of the shared decision-making process on lung cancer screening decisions. Cancer Med 11(3):790-797, 2022. e-Pub 2022. PMID: 34964284.
      24. Xu C, Smith GL, Chen YS, Checka CM, Giordano SH, Kaiser K, Lowenstein LM, Ma H, Mendoza TR, Peterson SK, Shih YT, Shete S, Tang C, Volk RJ, Sidey-Gibbons C. Short-form adaptive measure of financial toxicity from the Economic Strain and Resilience in Cancer (ENRICh) study: Derivation using modern psychometric techniques. PLoS One 17(8):e0272804, 2022. e-Pub 2022. PMID: 36006909.
      25. Lowenstein LM, Choi NJ, Hoffman KE, Volk RJ, Loeb S. Factors that influence clinicians' decisions to decrease active surveillance monitoring frequency or transition to watchful waiting for localised prostate cancer: a qualitative study. BMJ Open 11(11):e048347, 2021. e-Pub 2021. PMID: 34772748.
      26. Mohile SG, Mohamed MR, Xu H, Culakova E, Loh KP, Magnuson A, Flannery MA, Obrecht S, Gilmore N, Ramsdale E, Dunne RF, Wildes T, Plumb S, Patil A, Wells M, Lowenstein LM, Janelsins M, Mustian K, Hopkins JO, Berenberg J, Anthony N, Dale W. Evaluation of Geriatric Assessment and Management on the Toxic Effects of Cancer Treatment (GAP70+): A Clusterrandomised Study. Lancet 398(10314):1894-1904, 2021. e-Pub 2021. PMID: 34741815.
      27. Smith GL, Mendoza TR, Lowenstein LM, Shih YT. Financial Hardship in Survivorship Care Delivery. J Natl Cancer Inst Monogr 2021(57):10-14, 2021. e-Pub 2021. PMID: 34478512.
      28. Nishi SPE, Lowenstein LM, Mendoza TR, Lopez Olivo MA, Crocker LC, Sepucha K, Niu J, Volk RJ. Shared Decision-Making for Lung Cancer Screening: How Well Are We "Sharing"?. Chest 160(1):330-340, 2021. e-Pub 2021. PMID: 33556362.
      29. Maki KG, Liao K, Lowenstein LM, Lopez-Olivo MA, Volk RJ. Factors Associated With Obtaining Lung Cancer Screening Among Persons Who Smoke. MDM Policy Pract 6(2):23814683211067810, 2021. e-Pub 2021. PMID: 34993342.
      30. Lopez-Olivo MA, Minnix JA, Fox JG, Nishi SPE, Lowenstein LM, Maki KG, Leal VB, Tina Shih YC, Cinciripini PM, Volk RJ. Smoking cessation and shared decision-making practices about lung cancer screening among primary care providers. Cancer Med 10(4):1357-1365, 2021. e-Pub 2021. PMID: 33463091.
      31. Shih YT, Xu Y, Lowenstein LM, Volk RJ. Implementation of Shared Decision Making for Lung Cancer Screening Among the Privately Insured Nonelderly. MDM Policy Pract 6(1):2381468320984773, 2021. e-Pub 2021. PMID: 33598545.
      32. Zafar SN, Hu CY, Snyder RA, Cuddy A, You YN, Lowenstein LM, Volk RJ, Chang GJ. Predicting Risk of Recurrence After Colorectal Cancer Surgery in the United States: An Analysis of a Special Commission on Cancer National Study. Ann Surg Oncol 27(8):2740-2749, 2020. e-Pub 2020. PMID: 32080809.
      33. Lowenstein LM, Godoy MCB, Erasmus JJ, Zirari Z, Bennett A, Leal VB, Housten AJ, Volk RJ. Implementing Decision Coaching for Lung Cancer Screening in the Low-Dose Computed Tomography Setting. JCO Oncol Pract 16(8):e703-e725, 2020. e-Pub 2020. PMID: 32208092.
      34. Wong ML, Lichtman SM, Morrow GR, Simmons J, Hargraves T, Gross CP, Lund JL, Lowenstein LM, Walter LC, McDermott CL, Mohile SG, Cohen HJ. Geriatric oncology health services research: Cancer and Aging Research Group infrastructure core. J Geriatr Oncol 11(2):350-354, 2020. e-Pub 2020. PMID: 31326392.
      35. Mohile SG, Epstein RM, Hurria A, Heckler CE, Canin B, Culakova E, Duberstein P, Gilmore N, Xu H, Plumb S, Wells M, Lowenstein LM, Flannery MA, Janelsins M, Magnuson A, Loh KP, Kleckner AS, Mustian KM, Hopkins JO, Liu JJ, Geer J, Gorawara-Bhat R, Morrow GR, Dale W. Communication With Older Patients With Cancer Using Geriatric Assessment: A Cluster-Randomized Clinical Trial From the National Cancer Institute Community Oncology Research Program. JAMA Oncol 6(2):196-204, 2020. e-Pub 2020. PMID: 31697365.
      36. Volk RJ, Lowenstein LM, Leal VB, Escoto KH, Cantor SB, Munden RF, Rabius VA, Bailey L, Cinciripini PM, Lin H, Housten AJ, Luckett PG, Esparza A, Godoy MC, Bevers TB. Effect of a Patient Decision Aid on Lung Cancer Screening Decision-Making by Persons Who Smoke: A Randomized Clinical Trial. JAMA Netw Open 3(1):e1920362, 2020. e-Pub 2020. PMID: 32003822.
      37. Gilmore NJ, Canin B, Whitehead M, Sedenquist M, Griggs L, Finch L, Grossman V, Targia V, Wells M, Kamen C, Flannery M, Magnuson A, Plumb S, Obrecht S, Lowenstein LM, Lopez G, Anderson J, Berenberg J, Vogel V, Bearden J, Dale W, Mohile SG. Engaging older patients with cancer and their caregivers as partners in cancer research. Cancer 125(23):4124-4133, 2019. e-Pub 2019. PMID: 31420878.
      38. Lowenstein LM, Volk RJ, Cuddy A, Hempstead AP, You YN, Van Loon K, Millas S, Meyerhardt JA, Gavin P, Chang GJ. Patients' information needs and attitudes about post-treatment surveillance for colorectal cancer in the United States: a multi-perspective, mixed methods study. BMJ Open 9(8):e025888, 2019. e-Pub 2019. PMID: 31420381.
      39. Lowenstein LM, Volk RJ, Street R, Flannery M, Magnuson A, Epstein R, Mohile SG. Communication about geriatric assessment domains in advanced cancer settings: "Missed opportunities". J Geriatr Oncol 10(1):68-73, 2019. e-Pub 2019. PMID: 29884597.
      40. Lowenstein LM, Escoto KH, Leal VB, Bailey L, Bevers TB, Cantor SB, Cinciripini PM, Jacobs LE, Esparza A, Godoy MC, Housten AJ, Lin H, Luckett P, Munden RF, Rabius V, Volk RJ. Randomized trial of a patient-centered decision aid for promoting informed decisions about lung cancer screening: Implementation of a PCORI study protocol and lessons learned. Contemp Clin Trials 72:26-34, 2018. e-Pub 2018. PMID: 30010085.
      41. Housten AJ, Lowenstein LM, Leal VB, Volk RJ. Responsiveness of a Brief Measure of Lung Cancer Screening Knowledge. J Cancer Educ 33(4):842-846, 2018. e-Pub 2018. PMID: 27966194.
      42. Housten AJ, Lowenstein LM, Hoover DS, Leal VB, Kamath GR, Volk RJ. Limitations of the S-TOFHLA in measuring poor numeracy: a cross-sectional study. BMC Public Health 18(1):405, 2018. e-Pub 2018. PMID: 29587709.
      43. Hoffman AS, Hempstead AP, Housten AJ, Richards VF, Lowenstein LM, Leal VB, Volk RJ. Using a Patient Decision Aid Video to Assess Current and Former Smokers' Values About the Harms and Benefits of Lung Cancer Screening With Low-Dose Computed Tomography. MDM Policy Pract 3(1):2381468318769886, 2018. e-Pub 2018. PMID: 30288444.
      44. Williams GC, Lowenstein L, Cox JF, Patrick H, Adams MJ, Block RC, Rigby CS. Brief Report of Virtual Clinician Research Tools for Tobacco Dependence or Dyslipidemia. J Health Psychol 22(11):1463-1468, 2017. e-Pub 2016. PMID: 26929166.
      45. Hoffman AS, Lowenstein LM, Kamath GR, Housten AJ, Leal VB, Linder SK, Jibaja-Weiss ML, Raju GS, Volk RJ. An entertainment-education colorectal cancer screening decision aid for African American patients: A randomized controlled trial. Cancer 123(8):1401-1408, 2017. e-Pub 2017. PMID: 28001305.
      46. Street RL, Volk RJ, Lowenstein L, Michael Fordis C. Engaging Patients in the Uptake, Understanding, and Use of Evidence: Addressing Barriers and Facilitators of Successful Engagement. Patient Educ Couns 100(1):4, 2017. e-Pub 2017. PMID: 27450480.
      47. Lowenstein LM, Richards VF, Leal VB, Housten AJ, Bevers TB, Cantor SB, Cinciripini PM, Cofta-Woerpel LM, Escoto KH, Godoy MC, Linder SK, Munden RF, Volk RJ. A brief measure of Smokers' knowledge of lung cancer screening with low-dose computed tomography. Prev Med Rep 4:351-6, 2016. e-Pub 2016. PMID: 27512650.
      48. Hoffman A, Lowenstein LM, Kamath G, Housten AJ, Leal VB, Linder SK, Volk RJ. Entertainment-Education Colorectal Cancer Screening Decision Aid for African American Patients: A Randomized Controlled Trial (2D-6), October 23-26, 2016. 38th Annual Meeting of the Society for Medical Decision Making 37(1):E1-E334, 2016. e-Pub 2017. PMID: 28001305.
      49. Lowenstein LM, Mohile SG, Gil HH, Pandya C, Hemmerich J, Rodin M, Dale W. Which better predicts mortality among older men, a prostate cancer (PCa) diagnosis or vulnerability on the Vulnerable Elders Survey (VES-13)? A retrospective cohort study. J Geriatr Oncol 7(6):437-443, 2016. e-Pub 2016. PMID: 27480793.
      50. Carroll JK, Flocke SA, Sanders MR, Lowenstein L, Fiscella K, Epstein RM. Effectiveness of A Clinician Intervention to Improve Physical Activity Discussions in Underserved Adults. Fam Pract 33(5):488-91, 2016. e-Pub 2016. PMID: 27234988.
      51. Wong JK, Chen PC, Falvey J, Melvin AL, Lidder AK, Lowenstein LM, Miranpuri AS, Knight PA, Massey HT. Anticoagulation Reversal Strategies for Left Ventricular Assist Device Patients Presenting with Acute Intracranial Hemorrhage. ASAIO J 62(5):552-7, 2016. e-Pub 2016. PMID: 27347708.
      52. Mohile SG, Hurria A, Cohen HJ, Rowland JH, Leach CR, Arora NK, Canin B, Muss HB, Magnuson A, Flannery M, Lowenstein LM, Allore HG, Mustian KM, Demark-Wahnefried W, Extermann M, Ferrell B, Inouye SK, Studenski SA, Dale W. Improving the Quality of Survivorship for Older Adults with Cancer. Cancer 122(16):2459-568, 2016. e-Pub 2016. PMID: 27172129.
      53. Pandya C, Magnuson A, Dale W, Lowenstein LM, Fung C, Mohile SG. Association of Falls With Health-Related Quality of Life (HRQOL) in Older Cancer Survivors: A Population Based Study. J Geriatr Oncol 7(3):201-210, 2016. e-Pub 2016. PMID: 26907564.
      54. Mohile SG, Velarde C, Hurria A, Magnuson A, Lowenstein LM, Pandya C, O'Donovan A, Gorawara-Bhat R, Dale W. Geriatric Assessment-Guided Care Processes for Older Adults: A Delphi Consensus of Geriatric Oncology Experts. J Natl Compr Canc Netw 13(9):1120-30, 2015. e-Pub 2015. PMID: 26358796.
      55. Lowenstein LM, Ouellet JA, Dale W, Fan L, Gupta Mohile S. Preventive care in older cancer survivors. J Geriatr Oncol 6(2):85-92, 2015. e-Pub 2015. PMID: 25547206.
      56. Lowenstein, LM, Brown, K, Barrows, D, Foti, T, Scholer, L, LeVant, C, Schriefer, J. Continuous Quality Improvement in a Level IIIB NICU to Increase Human Milk Use at Day of Life 14, Day of Life 28, and Discharge. Infant, Child, and Adolescent Nutrition 6(3):137-143, 2014. e-Pub 2014.
      57. Augustine AH, Lowenstein LM, Harris WS, Shearer GC, Block RC. Treatment with omega-3 fatty acid ethyl-ester alters fatty acid composition of lipoproteins in overweight or obese adults with insulin resistance. Prostaglandins Leukot Essent Fatty Acids 90(2-3):69-75, 2014. e-Pub 2014. PMID: 24378016.
      58. Lowenstein LM, Perrin EM, Campbell MK, Tate DF, Cai J, Ammerman AS. Primary care providers' self-efficacy and outcome expectations for childhood obesity counseling. Child Obes 9(3):208-15, 2013. e-Pub 2013. PMID: 23635310.
      59. Lowenstein LM, Perrin EM, Berry D, Vu MB, Pullen Davis L, Cai J, Tzeng JP, Ammerman AS. Childhood obesity prevention: fathers' reflections with healthcare providers. Child Obes 9(2):137-43, 2013. e-Pub 2013. PMID: 23472966.
      60. Berry D, Colindres M, Vu MB, Davis LP, Chung G, Lowenstein LM, Ammerman AS. Latino Caregiver's Insight into Childhood Overweight Management and Relationships with their Health Care Providers In: Hispanic Health Care International. United States of America:11-20, 2009. e-Pub 2009.
      61. Yeh MC, Ickes SB, Lowenstein LM, Shuval K, Ammerman AS, Farris R, Katz DL. Understanding barriers and facilitators of fruit and vegetable consumption among a diverse multi-ethnic population in the USA. Health Promot Int 23(1):42-51, 2008. e-Pub 2008. PMID: 18182418.
      62. Jilcott SB, Laraia BA, Evenson KR, Lowenstein LM, Ammerman AS. A guide for developing intervention tools addressing environmental factors to improve diet and physical activity. Health Promot Pract 8(2):192-204, 2007. e-Pub 2007. PMID: 17384406.

      Invited Articles

      1. Lowenstein LM, Housten AJ, Volk RJ. Educating Men Diagnosed with Localized Prostate Cancer About Treatment Options: It Is More Than Life Expectancy. Ann Fam Med, 2016. e-Pub 2016.

      Review Articles

      1. Rogova A, Lowenstein LM, Reitzel LR, Casey K, Volk RJ. Missed Opportunities for Lung Cancer Screening Among Patients With Behavioral Health Disorders With Elevated Cigarette Smoking Rates: Lung Cancer Screening and Behavioral Health. Chest 168(1):269-275, 2025. e-Pub 2025. PMID: 39674344.
      2. Magnuson A, Loh KP, Stauffer F, Dale W, Gilmore N, Kadambi S, Klepin HD, Kyi K, Lowenstein LM, Phillips T, Ramsdale E, Schiaffino MK, Simmons JF Jr, Williams GR, Zittel J, Mohile S. Geriatric assessment for the practicing clinician: The why, what, and how. CA Cancer J Clin 74(6):496-518, 2024. e-Pub 2024. PMID: 39207229.
      3. Asare M, Abah E, Obiri-Yeboah D, Lowenstein LM, Lanning B. HPV Self-Sampling for Cervical Cancer Screening among Women Living with HIV in Low- and Middle-Income Countries: What Do We Know and What Can Be Done?. Healthcare 10(7):1270, 2022. e-Pub 2022. PMID: 35885798.
      4. Chapman AE, Elias R, Plotkin E, Lowenstein LM, Swartz K. Models of Care in Geriatric Oncology. J Clin Oncol 39(19):2195-2204, 2021. e-Pub 2021. PMID: 34043453.
      5. Housten AJ, Lowenstein LM, Hoffman A, Jacobs LE, Zirari Z, Hoover DS, Stacey D, Pratt G, Bevers TB, Volk RJ. A Review of the Presentation of Overdiagnosis in Cancer Screening Patient Decision Aids. MDM Policy Pract 4(2):2381468319881447, 2019. e-Pub 2019. PMID: 35187246.
      6. Volk RJ, Lowenstein LM, Escoto KH, Cantor SB, Munden RF, Rabius VA, Bailey L, Cinciripini PM, Lin H, Leal VB, Housten AJ, Luckett P, Esparza A, Godoy M, Bevers TB, 2019. e-Pub 2019. PMID: 38620344.
      7. Lowenstein LM, Basourakos SP, Williams MD, Troncoso P, Gregg JR, Thompson TC, Kim J. Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learned. Nat Rev Clin Oncol 16(3):168-184, 2019. e-Pub 2019. PMID: 30413793.
      8. Lowenstein LM, Deyter GMR, Nishi S, Wang T, Volk RJ. Shared decision-making conversations and smoking cessation interventions: critical components of low-dose CT lung cancer screening programs. Transl Lung Cancer Res 7(3):254-271, 2018. e-Pub 2018. PMID: 30050764.
      9. Nipp RD, Yao NA, Lowenstein LM, Buckner JC, Parker IR, Gajra A, Morrison VA, Dale W, Ballman KV. Pragmatic study designs for older adults with cancer: Report from the U13 conference. J Geriatr Oncol 7(4):234-41, 2016. e-Pub 2016. PMID: 27197914.

      Professional Educational Materials

      1. Lowenstein LM, Pan IE, Bailey L, Strader T, Krupski L, Lettieri JS, Leal VB, Volk RJ. Promoting Lung Cancer Screening: An Implementation Guide for Quitline's. North American Quitline Consortium (NAQC), 2022.
      2. Lowenstein LM, Chang GC, Cuddy A, Volk RJ. Colorectal Cancer Surveillance: A Decision-Support Tool For Patients and Providers Following Colon or Rectal Cancer Treatment. The University of Texas MD Anderson Cancer Center, 2017.
      3. Volk RJ, Lowenstein LM, Fordis M. Is Lung Cancer Screening Right for Me? A Decision Aid for People Considering Lung Cancer Screening with Low-Dose Computed Tomography. Agency for Healthcare Research and Quality (AHRQ), 2016.
      4. Volk RJ, Lowenstein LM, Fordis M. Is Lung Cancer Screening Right for Me? A Decision Making Tool for You and Your Health Care Professional. Patient Decision Aid. Agency for Healthcare Research and Quality (AHRQ), 2016.
      5. Volk RJ, Lowenstein LM, Fordis M. Lung Cancer Screening: A Summary Guide for Primary Care Clinicians. Patient Decision Aid. Agency for Healthcare Research and Quality (AHRQ), 2016.
      6. Volk RJ, Lowenstein LM, Fordis M. Lung Cancer Screening: A Clinician’s Checklist. Patient Decision Aid. Agency for Healthcare Research and Quality (AHRQ), 2016.

      Other Articles

      1. Dale, W, Klepin, HD, Williams, GR, Alibhai, S, Bergerot, CD, Brintzenhofeszoc, K, Hopkins, J, Jhawer, M, Katheria, V, Loh, KP, Lowenstein, LM, McKoy, JM, Noronha, V, Towe, TP, Rosko, A, Ruegg, T, Schiaffino, MK, Simmons, J, Subbiah, IM, Tew, WP, Webb, TL, Whitehead, MI, Somerfield, MR, Mohile, SG Erratum. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 43(36):3850, 2025. PMID: 41237358.
      2. Lopez-Olivo MA, Maki KG, Choi NJ, Hoffman RM, Shih YT, Lowenstein LM, Hicklen RS, Volk RJ Patient Adherence to Screening for Lung Cancer in the US: A Systematic Review and Meta-analysis. JAMA Netw Open 3(11):e2025102, 2020. PMID: 33196807.

      Abstracts

      1. Britton, Dey, Martinez, Rogova, Chen, Lowenstein LM, Sanchez, Reitzel. Implementation and Dissemination of Project SWITCH (Supporting Workplace Investment in Tobacco Control and Health): A Quality Improvement Study Protocol to Address Tobacco Use, Relapse Prevention, and Secondhand Smoke Exposure at Texas Lung Cancer Screening Centers 7(2), 2024. e-Pub 2024.
      2. Chang GJ, Gunn H, Barber A, Lowenstein LM, Paul Dohan D, Broering JM, Dockter T, Tan AD, Dueck AC, Bailey L, Lai-ming Chow S, Cleary RK, Mesleh M, Woodall C, Solfelt ML, Finlayson E. Surgical care, and outcomes in older patients with cancer through implementation of a pre-surgical toolkit (OPTI-Surg): Interim results of a phase III cluster randomized trial (Alliance A231601CD). 2023 ASCO Annual Meeting 41(16), 2023. e-Pub 2023.
      3. Sun C, Molina E, Schneider A, Harrison R, Westin S, Coleman R, Volk RJ, Lowenstein LM, Meyer L. Patient Preferences for Side Effects and Decision-Making Factors Associated with Maintenance Therapy for Ovarian Cancer. e-Pub 2019.
      4. Sun C, Molina E, Schneider A, Harrison R, Westin S, Coleman R, Volk RJ, Lowenstein LM, Meyer L. Patient Preferences for Maintenance Therapy vs. Routine Surveillance: Gain in Progression-Free Survival and Risks of Adverse Effects. e-Pub 2019.
      5. Smith GL, Lowenstein LM, Peterson SK, Rieber AG, Goodwin NA, Advani P, Jagsi R, Giordano SH, Volk RJ. Financial Toxicity of Cancer Care: Defining Pathways of Decline vs Resilience. 2018 ASCO Annual Meeting:e22150, 2018. e-Pub 2018.
      6. Housten A, Lowenstein LM, Stacey D, Volk RJ. Attention to Overdiagnosis in Cancer Screening Patient Decision Aids: An Examination of Aids from the Cochrane Systematic Review. 39th Annual Meeting of the Society for Medical Decision Making 38(1):E1-E371, 2018. e-Pub 2018.
      7. Cantor SB, Leal VB, Hoffman AS, Lowenstein LM, Volk RJ. Launching a Shared Decision Making Collaborative at a Comprehensive Cancer Center: Methods and Lessons Learned. 39th Annual Meeting of the Society for Medical Decision Making 38(1):E1-E371, 2018. e-Pub 2018.
      8. Volk RJ, Bevers TB, Cantor SB, Cinciripini P, Escoto K, Godoy M, Housten AJ, Leal VB, Lin H, Lowenstein LM, Munden R, Rabius V. Impact of a Patient Decision Aid on Smokers' Knowledge of Lung Cancer Screening Harms and Benefits: Project Inform, A Randomized Controlled Trial. 39th Annual Meeting of the Society for Medical Decision Making 38(1):E1-E371, 2018. e-Pub 2018.
      9. Cuddy A, Lowenstein LM, Hempstead AP, Richards VF, Loon KV, You YN, Volk RJ, Chang GJ. Patient Self-Advocacy in Decision Making Related To Post-Treatment Surveillance for Colorectal Cancer (PS 3-31). 38th Annual North American Meeting of the Society for Medical Decision Making 37(1):E1-E334. e-Pub 2017.
      10. Lowenstein LM, Hempstead AP, Richards VF, Leal VB, Housten AJ, Volk RJ. Responsiveness of a Brief Measure of Smokers' Knowledge of Lung Cancer Screening with Low-Dose Computed Tomography. 38th Annual North American Meeting of the Society for Medical Decision Making 37(1):E1-E334. e-Pub 2017.
      11. Hempstead AP, Leal VB, Richards VF, Lowenstein LM, Volk RJ. Acceptability and Efficacy of a Video-Based Patient Decision Aid About Lung Cancer Screening with Low-Dose Computed Tomography. 38th Annual North American Meeting of the Society for Medical Decision Making 37(1):E1-E334. e-Pub 2017.
      12. Lowenstein LM, Leal VB, Richards VF, Hempstead AP, Foxhall LE, Volk RJ. Primary Care Physicians' Lung Cancer Screening Practices: Comparisons Before and After the Centers for Medicare & Medicaid's National Coverage Determination. 38th Annual North American Meeting of the Society for Medical Decision Making 37(1):E1-E334, 2016. e-Pub 2016.
      13. Lowenstein LM, Epstein R, Yellamaty V, Plumb S, Conn K, Mohile SG. Missed Opportunities to Discuss Patient and Caregiver Aging Concerns in Oncology Clinical Encounters 49(Supplement 1, Abstract 29C):S130-S130, 2015. e-Pub 2015.
      14. Graves KD, Tucker-Seeley R, Gonzalez BD, Deshpande A, Lowenstein LM, Rowland JH. Aging and Cancer: Implications for Cognitive Outcomes and Clinical Encounters 49(Supplement 1, Abstract 29):S130-S130, 2015. e-Pub 2015.
      15. Tan NQP, An J, Hernandez M, Rogova A, Lowenstein LM, Hoffman RM, Volk RJ, Kinney AY. Knowledge, Perceived Benefits, and Screening Preferences Regarding Lung Cancer Screening Among Primary Care Patients in a Large Integrated Health System. American Society of Preventive Oncology (ASPO).
      16. Lee H, Jr, DeBoer R, Suchman L, Litt H, Nicosia F, Boscardin WJ, Loh KP, Walter L, Smith A, Lowenstein LM, Neuman H, Volk R, Hopkins J, Mohile S, Mercurio AM, Eskandar C, Schwarze M, Wong M. Effect of the Best Case/Worst Case-Geriatric Oncology (BC/WC-GeriOnc) Communication Tool on Shared Decision Making (SDM): A Pilot Cluster Randomized Controlled Trial. SIOG 2024 Annual Conference 15(7).
      Read More
      Less

      Patient Reviews


      CV information above last modified September 03, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top